Despite the current downward trend of Novo Nordisk, it is an excellent stock to buy for long-term gains, driven by the ...

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Here are four big drug/biotech stocks, LLY, RHHBY, NVS and PFE, which you should buy today for lucrative long-term returns.

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its ...

Plus: GLP-1 drugs like Ozempic have potential to treat cancer, COVID-19, heart disease, and many other diseases.

However, after its phase 1 success with TERN-601, it will raise more money by taking advantage of its soaring stock price and ...

Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has ... drug is administered orally – which makes it easier to take than Novo Nordisk’s Wegovy and Eli ...

Company earnings reported early in the quarter showed growth remained strong, with improved manufacturing volumes and steady ...

This week, the FDA approved J&J’s JNJ Tremfya for treating an inflammatory bowel disease condition (“IBD”), ulcerative ...

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

A first-of-its-kind analysis conducted as part of an investigation by journalists in eight countries found that some of the ...